Carboxylic esters derivatives of 2-thioxo-1H-2,3,4,5-tetrahydropyrido-[2,3-e]-1,3,4-triazepin-5-ones and 2-thioxo-1H-2,3,4,5-tetrahydro-1,3,4-benzotriazepin-5-ones. 1994

W Nawrocka, and H Liszkiewicz, and M Wilimowski, and M Rutkowska, and J Barczyńska, and L Kedzierska-Goździk, and W Wojewódzki, and A Szelag
Department of Technology of Drugs, School of Medicine, Wrocław, Poland.

2-Thioxo-1H-2,3,4,5-tetrahydropyrido[2,3-e]-1,3,4-triazep in -5-ones [I] and 2-thioxo-1H-2,3,4,-5-tetrahydro-1,3,4-benzotriazepin-5-ones [V] furnish with methyl, ethyl and phenyl chloroformates two series of the corresponding 3-methoxy-, ethoxy- and phenoxycarbonyl triazepines. In the pharmacological screening, compounds [I], [V] and [II] showed an antianxiety activity in the four plate test, compounds [II] and [III] inhibited the 5-HTP- induced head twitches, and compound [VI] showed an analgesic activity in the "writing" test. The replacement of the benzene ring by the pyridine one in triazepines is accompanied by the enhancement of anxiolytic activity as well as toxicity.

UI MeSH Term Description Entries
D007928 Lethal Dose 50 The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population. LD50,Dose 50, Lethal
D008297 Male Males
D005260 Female Females
D000700 Analgesics Compounds capable of relieving pain without the loss of CONSCIOUSNESS. Analgesic,Anodynes,Antinociceptive Agents,Analgesic Agents,Analgesic Drugs,Agents, Analgesic,Agents, Antinociceptive,Drugs, Analgesic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014151 Anti-Anxiety Agents Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. Anti-Anxiety Agent,Anti-Anxiety Drug,Anxiolytic,Anxiolytic Agent,Anxiolytic Agents,Tranquilizing Agents, Minor,Anti-Anxiety Drugs,Anti-Anxiety Effect,Anti-Anxiety Effects,Antianxiety Effect,Antianxiety Effects,Anxiolytic Effect,Anxiolytic Effects,Anxiolytics,Tranquillizing Agents, Minor,Agent, Anti-Anxiety,Agent, Anxiolytic,Agents, Anti-Anxiety,Agents, Anxiolytic,Agents, Minor Tranquilizing,Agents, Minor Tranquillizing,Anti Anxiety Agent,Anti Anxiety Agents,Anti Anxiety Drug,Anti Anxiety Drugs,Anti Anxiety Effect,Anti Anxiety Effects,Drug, Anti-Anxiety,Drugs, Anti-Anxiety,Effect, Anti-Anxiety,Effect, Antianxiety,Effect, Anxiolytic,Effects, Anti-Anxiety,Effects, Antianxiety,Effects, Anxiolytic,Minor Tranquilizing Agents,Minor Tranquillizing Agents
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

W Nawrocka, and H Liszkiewicz, and M Wilimowski, and M Rutkowska, and J Barczyńska, and L Kedzierska-Goździk, and W Wojewódzki, and A Szelag
May 1964, Journal of medicinal chemistry,
W Nawrocka, and H Liszkiewicz, and M Wilimowski, and M Rutkowska, and J Barczyńska, and L Kedzierska-Goździk, and W Wojewódzki, and A Szelag
April 1977, Journal of pharmaceutical sciences,
W Nawrocka, and H Liszkiewicz, and M Wilimowski, and M Rutkowska, and J Barczyńska, and L Kedzierska-Goździk, and W Wojewódzki, and A Szelag
December 2015, Organic letters,
W Nawrocka, and H Liszkiewicz, and M Wilimowski, and M Rutkowska, and J Barczyńska, and L Kedzierska-Goździk, and W Wojewódzki, and A Szelag
June 2008, Organic & biomolecular chemistry,
W Nawrocka, and H Liszkiewicz, and M Wilimowski, and M Rutkowska, and J Barczyńska, and L Kedzierska-Goździk, and W Wojewódzki, and A Szelag
June 1974, Journal of pharmaceutical sciences,
W Nawrocka, and H Liszkiewicz, and M Wilimowski, and M Rutkowska, and J Barczyńska, and L Kedzierska-Goździk, and W Wojewódzki, and A Szelag
January 1996, Acta poloniae pharmaceutica,
W Nawrocka, and H Liszkiewicz, and M Wilimowski, and M Rutkowska, and J Barczyńska, and L Kedzierska-Goździk, and W Wojewódzki, and A Szelag
January 1997, Farmaco (Societa chimica italiana : 1989),
W Nawrocka, and H Liszkiewicz, and M Wilimowski, and M Rutkowska, and J Barczyńska, and L Kedzierska-Goździk, and W Wojewódzki, and A Szelag
August 1987, Il Farmaco; edizione scientifica,
W Nawrocka, and H Liszkiewicz, and M Wilimowski, and M Rutkowska, and J Barczyńska, and L Kedzierska-Goździk, and W Wojewódzki, and A Szelag
January 1979, Il Farmaco; edizione scientifica,
W Nawrocka, and H Liszkiewicz, and M Wilimowski, and M Rutkowska, and J Barczyńska, and L Kedzierska-Goździk, and W Wojewódzki, and A Szelag
May 2003, Organic & biomolecular chemistry,
Copied contents to your clipboard!